Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
eli lilly
3
×
investing
3
×
life sciences
national blog main
national top stories
roche
3
×
san francisco blog main
san francisco top stories
aduro biotech
alzheimer's disease
biogen
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
fda
genentech
indiana blog main
indiana top stories
national
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
What
bio
drug
roundup
alliance
alzheimer’s
approval
blueprint
bristol
buy
calls
cancer
candidate
changing
color
companies
crispr
currently
days
different
fail
fda
gene
growing
hours
increases
kudos
latest
leaves
marketing
medicines
muscle
myers’s
notifying
october
pact
pharmaceutical
phone
plan
prescription
price
Language
unset
Current search:
roche
×
investing
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
